Clinical Trials Browser

Interventional × Metastatic Urothelial Cancer × pembrolizumab × Clear all

NCT03547973 2026-03-16

TROPHY U-01

Phase 2 Recruiting

827 enrolled 1 FDA

Metastatic Urothelial Cancer

NCT02826564 2024-07-17

Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer

Phase 1 Completed

Metastatic Urothelial Cancer